Literature DB >> 18760751

Epidemiology of chronic kidney disease in heart failure.

Ali Ahmed1, Ruth C Campbell.   

Abstract

Heart failure is common and is associated with a poor prognosis. Chronic kidney disease is common in heart failure and shares many risk factors with heart failure, such as age, hypertension, diabetes, and coronary artery disease. Over half of all patients who have heart failure may have moderate-to-severe chronic kidney disease. The presence of chronic kidney disease is associated with increased morbidity and mortality, yet it is also associated with underuse of evidence-based heart failure therapy that may reduce morbidity and mortality. Understanding the epidemiology and outcomes of chronic kidney disease in heart failure is essential to ensure proper management of these patients.

Entities:  

Mesh：

Year:  2008        PMID： 18760751      PMCID： PMC2900793          DOI： 10.1016/j.hfc.2008.03.008

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


  82 in total

1.  Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin.

Authors:  A Levin; C R Thompson; J Ethier; E J Carlisle; S Tobe; D Mendelssohn; E Burgess; K Jindal; B Barrett; J Singer; O Djurdjev
Journal:  Am J Kidney Dis       Date:  1999-07       Impact factor: 8.860

2.  A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

Authors:  Eric J Eichhorn; Michael J Domanski; Heidi Krause-Steinrauf; Michael R Bristow; Philip W Lavori
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

3.  Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

Authors:  Alan S Go; Jingrong Yang; Lynn M Ackerson; Krista Lepper; Sean Robbins; Barry M Massie; Michael G Shlipak
Journal:  Circulation       Date:  2006-06-05       Impact factor: 29.690

4.  Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.

Authors:  Scott D Solomon; Madeline M Rice; Kathleen A Jablonski; Powell Jose; Michael Domanski; Marc Sabatine; Bernard J Gersh; Jean Rouleau; Marc A Pfeffer; Eugene Braunwald
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

5.  Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals.

Authors:  Linda F Fried; Michael G Shlipak; Casey Crump; Anthony J Bleyer; John S Gottdiener; Richard A Kronmal; Lewis H Kuller; Anne B Newman
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

6.  Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction.

Authors:  Powell Jose; Hicham Skali; Nagesh Anavekar; Charles Tomson; Harlan M Krumholz; Jean L Rouleau; Lemuel Moye; Marc A Pfeffer; Scott D Solomon
Journal:  J Am Soc Nephrol       Date:  2006-08-23       Impact factor: 10.121

7.  Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease.

Authors:  Donal N Reddan; Lynda Anne Szczech; Robert H Tuttle; Linda K Shaw; Robert H Jones; Steve J Schwab; Mark Stafford Smith; Robert M Califf; Daniel B Mark; William F Owen
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

8.  National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.

Authors:  Frederick A Masoudi; Saif S Rathore; Yongfei Wang; Edward P Havranek; Jeptha P Curtis; JoAnne Micale Foody; Harlan M Krumholz
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

9.  Inpatients with coronary heart disease have a high prevalence of chronic kidney disease based on estimated glomerular filtration rate (eGFR) in China.

Authors:  Hao Liu; Jinming Yu; Fang Chen; Jue Li; Dayi Hu
Journal:  Heart Vessels       Date:  2007-07-20       Impact factor: 2.037

10.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690
View more
  40 in total

1.  Combining angiotensin receptor blockers with ACE inhibitors in elderly patients.

Authors:  Shuchi Anand; Manjula Kurella Tamura
Journal:  Am J Kidney Dis       Date:  2011-10-13       Impact factor: 8.860

2.  Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial.

Authors:  C Barrett Bowling; Paul W Sanders; Richard M Allman; William J Rogers; Kanan Patel; Inmaculada B Aban; Michael W Rich; Bertram Pitt; Michel White; George C Bakris; Gregg C Fonarow; Ali Ahmed
Journal:  Int J Cardiol       Date:  2012-01-17       Impact factor: 4.164

3.  Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.

Authors:  Ali Ahmed; Gregg C Fonarow; Yan Zhang; Paul W Sanders; Richard M Allman; Donna K Arnett; Margaret A Feller; Thomas E Love; Inmaculada B Aban; Raynald Levesque; O James Ekundayo; Louis J Dell'Italia; George L Bakris; Michael W Rich
Journal:  Am J Med       Date:  2012-02-07       Impact factor: 4.965

4.  Leveraging electronic health record data for clinical trial planning by assessing eligibility criteria's impact on patient count and safety.

Authors:  James R Rogers; Jovana Pavisic; Casey N Ta; Cong Liu; Ali Soroush; Ying Kuen Cheung; George Hripcsak; Chunhua Weng
Journal:  J Biomed Inform       Date:  2022-02-18       Impact factor: 6.317

5.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

6.  Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease.

Authors:  Ali Ahmed; Michael W Rich; Michael Zile; Paul W Sanders; Kanan Patel; Yan Zhang; Inmaculada B Aban; Thomas E Love; Gregg C Fonarow; Wilbert S Aronow; Richard M Allman
Journal:  Am J Med       Date:  2013-02       Impact factor: 4.965

7.  Hip fractures and heart failure: findings from the Cardiovascular Health Study.

Authors:  Laura Carbone; Petra Buzková; Howard A Fink; Jennifer S Lee; Zhao Chen; Ali Ahmed; Susmita Parashar; John R Robbins
Journal:  Eur Heart J       Date:  2009-11-04       Impact factor: 29.983

8.  The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease.

Authors:  Amber O Molnar; William Petrcich; Matthew A Weir; Amit X Garg; Michael Walsh; Manish M Sood
Journal:  Nephrol Dial Transplant       Date:  2020-05-01       Impact factor: 5.992

9.  Chronic kidney disease and outcomes of lower extremity revascularization for peripheral artery disease.

Authors:  Nathaniel R Smilowitz; Nipun Bhandari; Jeffrey S Berger
Journal:  Atherosclerosis       Date:  2019-12-24       Impact factor: 5.162

10.  A New View of Iron Management in Heart Failure: What Nephrologists Need to Know.

Authors:  Nupur N Uppal; Steven Fishbane
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.